CD8A and neoplasm: By doing so, the immunosuppressive tumor microenvironment (TME) was rebuilt with increased tumor‐infiltrated CD8+ T cells (Scheme 1B), and DNDA thus showed enhanced antitumor efficacy in combination with PDL1 antibody in MC38 colon cancer and B16 melanoma animal models.